{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:19:02Z","timestamp":1791296342140,"version":"4.1.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.amjmed.2013.05.002","type":"journal-article","created":{"date-parts":[[2013,7,3]],"date-time":"2013-07-03T19:46:46Z","timestamp":1372880806000},"page":"834-837","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Amlodipine Reduces Cardiac Iron Overload in Patients with Thalassemia Major: A Pilot Trial"],"prefix":"10.1016","volume":"126","author":[{"given":"Juliano Lara","family":"Fernandes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika Fontana","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleber","family":"Fertrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio Rizzi","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Loggetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Piga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Verissimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara T.","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.amjmed.2013.05.002_bib1","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1586\/ehm.11.29","article-title":"Complications of thalassemia major and their treatment","volume":"4","author":"Borgna-Pignatti","year":"2011","journal-title":"Expert Rev Hematol"},{"issue":"4","key":"10.1016\/j.amjmed.2013.05.002_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1517\/14740338.2010.497138","article-title":"Introduction of higher doses of deferasirox: better\u00a0efficacy but not effective iron removal from the heart and increased risks of serious toxicities","volume":"9","author":"Kontoghiorghes","year":"2010","journal-title":"Expert Opin Drug Saf"},{"issue":"9","key":"10.1016\/j.amjmed.2013.05.002_bib3","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/nm920","article-title":"L-type Ca2+ channels provide a major pathway for iron entry into cardiomyocytes in iron-overload cardiomyopathy","volume":"9","author":"Oudit","year":"2003","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.amjmed.2013.05.002_bib4","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00109-005-0029-x","article-title":"Role of L-type Ca2+ channels in iron transport and iron-overload cardiomyopathy","volume":"84","author":"Oudit","year":"2006","journal-title":"J\u00a0Mol Med (Berl)"},{"issue":"11","key":"10.1016\/j.amjmed.2013.05.002_bib5","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1161\/01.RES.84.11.1302","article-title":"Modulation of iron uptake in heart by L-type Ca2+ channel modifiers: possible implications in iron overload","volume":"84","author":"Tsushima","year":"1999","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.amjmed.2013.05.002_bib6","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/mrm.21744","article-title":"Myocardial T2* measurements in iron-overloaded thalassemia: an in vivo study to investigate optimal methods of quantification","volume":"60","author":"He","year":"2008","journal-title":"Magn Reson Med"},{"issue":"4","key":"10.1016\/j.amjmed.2013.05.002_bib7","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2004-10-3982","article-title":"MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients","volume":"106","author":"Wood","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.amjmed.2013.05.002_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1532-429X-10-12","article-title":"Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction","volume":"10","author":"Tanner","year":"2008","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"issue":"14","key":"10.1016\/j.amjmed.2013.05.002_bib9","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","article-title":"A\u00a0randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance","volume":"115","author":"Tanner","year":"2007","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.amjmed.2013.05.002_bib10","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","article-title":"Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis","volume":"107","author":"Pennell","year":"2006","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.amjmed.2013.05.002_bib11","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1182\/blood-2009-04-217455","article-title":"Efficacy of deferasirox in reducing and preventing cardiac iron overload in beta-thalassemia","volume":"115","author":"Pennell","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.amjmed.2013.05.002_bib12","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1182\/blood-2003-03-0807","article-title":"Labile plasma iron in iron overload: redox activity and susceptibility to chelation","volume":"102","author":"Esposito","year":"2003","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.amjmed.2013.05.002_bib13","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm1542","article-title":"Ca2+ channel blockers reverse iron overload by a new mechanism via divalent metal transporter-1","volume":"13","author":"Ludwiczek","year":"2007","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.amjmed.2013.05.002_bib14","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00467-004-1781-9","article-title":"Efficacy and safety of prolonged amlodipine treatment in hypertensive children","volume":"20","author":"Flynn","year":"2005","journal-title":"Pediatr Nephrol"},{"issue":"19","key":"10.1016\/j.amjmed.2013.05.002_bib15","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs","volume":"341","author":"Abernethy","year":"1999","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.amjmed.2013.05.002_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00002018-199615020-00002","article-title":"A\u00a0comparative review of the adverse effects of calcium antagonists","volume":"15","author":"Dougall","year":"1996","journal-title":"Drug Saf"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934313003926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934313003926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:01:01Z","timestamp":1757581261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934313003926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0002934313003926"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2013.05.002","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amlodipine Reduces Cardiac Iron Overload in Patients with Thalassemia Major: A Pilot Trial","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2013.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}